No Data
No Data
Shaanxi Panlong Pharmaceutical (002864.SZ): Cumulatively repurchased 0.35% of the shares.
On September 2, Gelunhui reported that shaanxi panlong pharmaceutical (002864.SZ) announced that as of the close on August 30, 2024, the company repurchased a total of 373,200 shares of the company through the use of its own funds in a centralized bidding manner, accounting for 0.35% of the total share capital. The highest price was 27.81 yuan/share, the lowest price was 25.71 yuan/share, and the total amount paid was RMB 9,994,330.25 (excluding trading expenses).
Panlong Pharmaceutical: 2024 Semi-Annual Report Summary
Panlong Pharmaceutical: Semi-Annual Report 2024
Shenzhen Transsion Holdings Co., Ltd.: In the first half of the year, the net income was 2.852 billion yuan, a year-on-year increase of 35.70%, and a planned dividend of 10 with a price of 15 yuan; Haier Smarthome: In the first half of the year, the net i
[Performance Data] Shennan Circuits (002916.SZ): The net income for the first half of the year was 0.987 billion yuan, with a year-on-year growth of 108.32%. Qianjiang Motorcycle (000913.SZ): The net income for the first half of the year was 0.349 billion yuan, with a year-on-year growth of 24.44%. Shanxi Coking Coal (000983.SZ): The net income for the first half of the year was 1.966 billion yuan, with a year-on-year decrease of 56.47%. Shenzhen Desay Battery Technology (000049.SZ): The net income for the first half of the year was 0.108 billion yuan, with a year-on-year decrease of 38.70%. Zhuzhou Kibing Group (601636.SH): The net income for the first half of the year was 0.811 billion yuan, with a year-on-year growth of 25.
Shaanxi Panlong Pharmaceutical (002864.SZ): plans to build Panlong Life Science Industrial Park.
On August 27th, Gelonhui announced that according to the company's development plan, Shaanxi Panlong Pharmaceutical intends to invest in purchasing land use rights and building the Panlong Life Science Industrial Park in the Xi'an High-tech Zone, with a total investment not exceeding 1.005 billion yuan. The specific project investment amount will be subject to the official investment proposal.
Shaanxi Panlong Pharmaceutical (002864.SZ): The net income for the first half of the year was 59.6533 million yuan, a year-on-year increase of 9.95%.
On August 27, Guolonghui reported that Shaanxi Panlong Pharmaceutical (002864.SZ) released its semi-annual report for 2024, with a reported revenue of 0.455 billion yuan, a year-on-year decrease of 8.93%; net income attributable to shareholders of the listed company was 59.6533 million yuan, a year-on-year increase of 9.95%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 50.7341 million yuan, a year-on-year decrease of 1.10%; and the basic earnings per share were 0.57 yuan.
No Data
No Data